Business leaders and life science advocates urged lawmakers to oppose federal drug pricing legislation that would stymie life-saving research, slash billions from California’s economy and wipe out more than 200,000 biopharmaceutical jobs statewide.
PRESS RELEASE - BizFed Opposes Drug Pricing Restrictions
